Recombinant Human Erythropoietin Is Associated with Increased Overall Survival in Patients with Multiple Myeloma

Publisher： Karger

E-ISSN： 1421-9662|117|3|162-167

ISSN： 0001-5792

Source： Acta Haematologica, Vol.117, Iss.3, 2006-12, pp. : 162-167

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Use of Erythropoietin in Patients with Multiple Myeloma

By  

Oncology Research and Treatment, Vol. 26, Iss. 1, 2003-03 ,pp. : 80-84

Karger

Access to resources Recommend Favorite

Overall survival of relapsed and refractory multiple myeloma patients after adjusting for crossover in the MM‐003 trial for pomalidomide plus low‐dose dexamethasone

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 168, Iss. 6, 2015-03 ,pp. : 820-823

John Wiley & Sons Inc

Access to resources Recommend Favorite

Renal impairment at presentation in multiple myeloma continues to be associated with poor survival

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 169, Iss. 6, 2015-06 ,pp. : 901-902

John Wiley & Sons Inc

Access to resources Recommend Favorite

Recombinant Human Erythropoietin for the Treatment of Anaemia in Patients with Chronic Idiopathic Myelofibrosis

By  

Acta Haematologica, Vol. 117, Iss. 3, 2006-12 ,pp. : 156-161

Karger

Access to resources Recommend Favorite

Hepcidin Serum Levels and Resistance to Recombinant Human Erythropoietin Therapy in Haemodialysis Patients

By  

Acta Haematologica, Vol. 122, Iss. 4, 2009-10 ,pp. : 226-229

Karger

Access to resources Recommend Favorite